Cathelicidin preserves intestinal barrier function in polymicrobial sepsis

Abstract Objectives The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation. Previous studies reported that cathelicidin is differentially expr...

Full description

Bibliographic Details
Main Authors: Jeffery Ho, Hung Chan, Yonghao Liang, Xiaodong Liu, Lin Zhang, Qing Li, Yuchen Zhang, Judeng Zeng, Felix N. Ugwu, Idy H. T. Ho, Wei Hu, Johnny C. W. Yau, Sunny H. Wong, Wai Tat Wong, Lowell Ling, Chi H. Cho, Richard L. Gallo, Tony Gin, Gary Tse, Jun Yu, Matthew T. V. Chan, Czarina C. H. Leung, William K. K. Wu
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-020-2754-5
id doaj-7d62813e15f84a7bb7e67e903aed1b8b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jeffery Ho
Hung Chan
Yonghao Liang
Xiaodong Liu
Lin Zhang
Qing Li
Yuchen Zhang
Judeng Zeng
Felix N. Ugwu
Idy H. T. Ho
Wei Hu
Johnny C. W. Yau
Sunny H. Wong
Wai Tat Wong
Lowell Ling
Chi H. Cho
Richard L. Gallo
Tony Gin
Gary Tse
Jun Yu
Matthew T. V. Chan
Czarina C. H. Leung
William K. K. Wu
spellingShingle Jeffery Ho
Hung Chan
Yonghao Liang
Xiaodong Liu
Lin Zhang
Qing Li
Yuchen Zhang
Judeng Zeng
Felix N. Ugwu
Idy H. T. Ho
Wei Hu
Johnny C. W. Yau
Sunny H. Wong
Wai Tat Wong
Lowell Ling
Chi H. Cho
Richard L. Gallo
Tony Gin
Gary Tse
Jun Yu
Matthew T. V. Chan
Czarina C. H. Leung
William K. K. Wu
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
Critical Care
LL-37
Sepsis
Bacterial translocation
Antimicrobial peptide
author_facet Jeffery Ho
Hung Chan
Yonghao Liang
Xiaodong Liu
Lin Zhang
Qing Li
Yuchen Zhang
Judeng Zeng
Felix N. Ugwu
Idy H. T. Ho
Wei Hu
Johnny C. W. Yau
Sunny H. Wong
Wai Tat Wong
Lowell Ling
Chi H. Cho
Richard L. Gallo
Tony Gin
Gary Tse
Jun Yu
Matthew T. V. Chan
Czarina C. H. Leung
William K. K. Wu
author_sort Jeffery Ho
title Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
title_short Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
title_full Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
title_fullStr Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
title_full_unstemmed Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
title_sort cathelicidin preserves intestinal barrier function in polymicrobial sepsis
publisher BMC
series Critical Care
issn 1364-8535
publishDate 2020-02-01
description Abstract Objectives The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation. Previous studies reported that cathelicidin is differentially expressed in various tissues in sepsis. However, its role in sepsis-induced intestinal barrier dysfunction has not been investigated. Design To examine the role of cathelicidin in polymicrobial sepsis, cathelicidin wild-(Cnlp +/+) and knockout (Cnlp −/−) mice underwent cecal-ligation and puncture (CLP) followed by the assessment of septic mortality and morbidity as well as histological, biochemical, immunological, and transcriptomic analyses in the ileal tissues. We also evaluated the prophylactic and therapeutic efficacies of vitamin D3 (an inducer of endogenous cathelicidin) in the CLP-induced murine polymicrobial sepsis model. Results The ileal expression of cathelicidin was increased by three-fold after CLP, peaking at 4 h. Knockout of Cnlp significantly increased 7-day mortality and was associated with a higher murine sepsis score. Alcian-blue staining revealed a reduced number of mucin-positive goblet cells, accompanied by reduced mucin expression. Increased number of apoptotic cells and cleavage of caspase-3 were observed. Cnlp deletion increased intestinal permeability to 4kD fluorescein-labeled dextran and reduced the expression of tight junction proteins claudin-1 and occludin. Notably, circulating bacterial DNA load increased more than two-fold. Transcriptome analysis revealed upregulation of cytokine/inflammatory pathway. Depletion of Cnlp induced more M1 macrophages and neutrophils compared with the wild-type mice after CLP. Mice pre-treated with cholecalciferol (an inactive form of vitamin D3) or treated with 1alpha, 25-dihydroxyvitamin D3 (an active form of VD3) had decreased 7-day mortality and significantly less severe symptoms. Intriguingly, the administration of cholecalciferol after CLP led to worsened 7-day mortality and the associated symptoms. Conclusions Endogenous cathelicidin promotes intestinal barrier integrity accompanied by modulating the infiltration of neutrophils and macrophages in polymicrobial sepsis. Our data suggested that 1alpha, 25-dihydroxyvitamin D3 but not cholecalciferol is a potential therapeutic agent for treating sepsis.
topic LL-37
Sepsis
Bacterial translocation
Antimicrobial peptide
url https://doi.org/10.1186/s13054-020-2754-5
work_keys_str_mv AT jefferyho cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT hungchan cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT yonghaoliang cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT xiaodongliu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT linzhang cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT qingli cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT yuchenzhang cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT judengzeng cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT felixnugwu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT idyhtho cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT weihu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT johnnycwyau cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT sunnyhwong cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT waitatwong cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT lowellling cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT chihcho cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT richardlgallo cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT tonygin cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT garytse cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT junyu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT matthewtvchan cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT czarinachleung cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
AT williamkkwu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis
_version_ 1724270647016685568
spelling doaj-7d62813e15f84a7bb7e67e903aed1b8b2021-02-14T12:20:08ZengBMCCritical Care1364-85352020-02-0124111610.1186/s13054-020-2754-5Cathelicidin preserves intestinal barrier function in polymicrobial sepsisJeffery Ho0Hung Chan1Yonghao Liang2Xiaodong Liu3Lin Zhang4Qing Li5Yuchen Zhang6Judeng Zeng7Felix N. Ugwu8Idy H. T. Ho9Wei Hu10Johnny C. W. Yau11Sunny H. Wong12Wai Tat Wong13Lowell Ling14Chi H. Cho15Richard L. Gallo16Tony Gin17Gary Tse18Jun Yu19Matthew T. V. Chan20Czarina C. H. Leung21William K. K. Wu22Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Medicine and Therapeutics, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongLaboratory of Molecular Pharmacology, School of Pharmacy, Southwest Medical UniversityDepartment of Dermatology, The University of CaliforniaDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Medicine and Therapeutics, The Chinese University of Hong KongState Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Sciences, and Centre for Gut Microbiota Research, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongAbstract Objectives The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation. Previous studies reported that cathelicidin is differentially expressed in various tissues in sepsis. However, its role in sepsis-induced intestinal barrier dysfunction has not been investigated. Design To examine the role of cathelicidin in polymicrobial sepsis, cathelicidin wild-(Cnlp +/+) and knockout (Cnlp −/−) mice underwent cecal-ligation and puncture (CLP) followed by the assessment of septic mortality and morbidity as well as histological, biochemical, immunological, and transcriptomic analyses in the ileal tissues. We also evaluated the prophylactic and therapeutic efficacies of vitamin D3 (an inducer of endogenous cathelicidin) in the CLP-induced murine polymicrobial sepsis model. Results The ileal expression of cathelicidin was increased by three-fold after CLP, peaking at 4 h. Knockout of Cnlp significantly increased 7-day mortality and was associated with a higher murine sepsis score. Alcian-blue staining revealed a reduced number of mucin-positive goblet cells, accompanied by reduced mucin expression. Increased number of apoptotic cells and cleavage of caspase-3 were observed. Cnlp deletion increased intestinal permeability to 4kD fluorescein-labeled dextran and reduced the expression of tight junction proteins claudin-1 and occludin. Notably, circulating bacterial DNA load increased more than two-fold. Transcriptome analysis revealed upregulation of cytokine/inflammatory pathway. Depletion of Cnlp induced more M1 macrophages and neutrophils compared with the wild-type mice after CLP. Mice pre-treated with cholecalciferol (an inactive form of vitamin D3) or treated with 1alpha, 25-dihydroxyvitamin D3 (an active form of VD3) had decreased 7-day mortality and significantly less severe symptoms. Intriguingly, the administration of cholecalciferol after CLP led to worsened 7-day mortality and the associated symptoms. Conclusions Endogenous cathelicidin promotes intestinal barrier integrity accompanied by modulating the infiltration of neutrophils and macrophages in polymicrobial sepsis. Our data suggested that 1alpha, 25-dihydroxyvitamin D3 but not cholecalciferol is a potential therapeutic agent for treating sepsis.https://doi.org/10.1186/s13054-020-2754-5LL-37SepsisBacterial translocationAntimicrobial peptide